Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Human Genetics, |
RCV000660345 | SCV000782405 | likely pathogenic | Tuberous sclerosis 2 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000660345 | SCV001578712 | pathogenic | Tuberous sclerosis 2 | 2018-05-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe924Leufs*24) in the TSC2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with TSC2-related disease. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV000660345 | SCV002040960 | likely pathogenic | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing |